
The new junk bond offering will further reduce the risk that Rite-Aid will vanish in a puff of smoke. McKesson (NYSE:MCK), which sells about $13 billion in drugs to Rite-Aid, will also be relieved.
Wow, this company has more lives than a cat with an afterlife.
Of course, restructuring an excessive debt burden is not the same as saying the future looks rosy. Recent same-store sales trends don’t dispel Rite-Aid’s nickname as “the turnaround that never turns around.” The NYSE is once again threatening to delist Rite-Aid if its stock stays below the price of a Sausage McMuffin.
FWIW, below is a quick primer on their debt load and the new offering.
This snapshot of Rite-Aid’s debt load was presented by the company in an April 2010 presentation.

See What's Next for Rite-Aid for my still-relevant thoughts on their next steps.
“the turnaround that never turns around.”
ReplyDeleteGREAT LINE!!
FYI, Rite-Aid completed the transaction described in the post above. See Rite Aid Completes Refinancing Transactions That Extend Debt Maturities and Lower Interest Expense.
ReplyDeleteAdam